Frontiers in Medicine | |
Case Report: Bullous Lung Disease Following COVID-19 | |
Prachi Pednekar1  Robert Homer2  Kwesi Amoah3  Changwan Ryu4  Denyse D. Lutchmansingh4  | |
[1] Department of Internal Medicine, Bridgeport Hospital, Bridgeport, CT, United States;Department of Pathology, Yale School of Medicine, New Haven, CT, United States;Section of Pulmonary, Critical Care, and Sleep Medicine, Bridgeport Hospital, Bridgeport, CT, United States;Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, United States; | |
关键词: COVID-19; bullous lung disease; post-acute COVID-19; SARS CoV-2; post-COVID “Long Haulers”; | |
DOI : 10.3389/fmed.2021.770778 | |
来源: DOAJ |
【 摘 要 】
More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiological abnormalities up to 3 months after symptom onset. These radiological abnormalities are variable and most commonly include ground-glass opacities, reticulations, mosaic attenuation, parenchymal bands, interlobular septal thickening, bronchiectasis, and fibrotic-like changes. However, in this case report, we describe findings of bullous lung disease as a complication of SARS CoV-2 infection. As the pandemic continues, there is a need to understand the multiple respiratory manifestations of post-acute sequelae of COVID-19. We, therefore, present this case to add to the current body of literature describing pulmonary disease as a consequence of SARS CoV-2 infection.
【 授权许可】
Unknown